During the past decade, Hospital Virgen de la Salud conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 27 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 19 clinical trials were completed. i.e. 63.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Virgen de la Salud" #1 sponsor was "Spanish Breast Cancer Research Group" with 18 trials, followed by "PETHEMA Foundation" with 7 trials sponsored, "Pfizer" with 7 trials sponsored, "Spanish Oncology Genito-Urinary Group" with 7 trials sponsored and "Hospital Virgen de la Salud" with 7 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Virgen de la Salud" #1 collaborator was "Bristol-Myers Squibb" with 7 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Virgen de la Salud" are "Breast Cancer" (15 trials), "Coronary Artery Disease" (7 trials), "Atrial Fibrillation" (4 trials), "Multiple Myeloma" (4 trials) and "Covid19" (3 trials). Many other conditions were trialed in "Hospital Virgen de la Salud" in a lesser frequency.

Most popular intervention types in "Hospital Virgen de la Salud" are "Drug" (72 trials), "Device" (21 trials), "Other" (15 trials), "Procedure" (10 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (9 trials), "Paclitaxel" (5 trials), "Doxorubicin" (4 trials), "Fulvestrant" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Virgen de la Salud" are 105 trials for "All" genders, 28 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Virgen de la Salud". undefined are not yet recruiting, 12 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Hospital Virgen de la Salud, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Virgen de la Salud, 6 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 15 trials that are defined as “Not Applicable".